Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2017, Article ID 3106041, 6 pages
https://doi.org/10.1155/2017/3106041
Research Article

GH Responsiveness to Combined GH-Releasing Hormone and Arginine Administration in Obese Patients with Fibromyalgia Syndrome

1Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
2Experimental Laboratory for Auxo-Endocrinological Research, Istituto Auxologico Italiano, IRCCS, Milan and Verbania, Italy
3Division of Auxology, Istituto Auxologico Italiano, IRCCS, Verbania, Italy
4Orthopedic Rehabilitation Unit, IRCCS, Istituto Auxologico Italiano, IRCCS, Verbania, Italy

Correspondence should be addressed to Antonello E. Rigamonti; ti.iminu@itnomagir.ollenotna

Received 7 April 2017; Revised 25 May 2017; Accepted 30 May 2017; Published 28 June 2017

Academic Editor: Andreas Höflich

Copyright © 2017 Antonello E. Rigamonti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. Clauw, “Fibromyalgia: a clinical review,” JAMA, vol. 311, no. 15, pp. 1547–1555, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Rahman, M. Underwood, and D. Carnes, “Fibromyalgia,” BMJ, vol. 348, article g1224, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Cuatrecasas, M. J. Gonzalez, C. Alegre et al., “High prevalence of growth hormone deficiency in severe fibromyalgia syndromes,” Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 9, pp. 4331–4337, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. K. D. Jones, P. Deodhar, A. Lorentzen, R. M. Bennett, and A. A. Deodhar, “Growth hormone perturbations in fibromyalgia: a review,” Seminars in Arthritis and Rheumatism, vol. 36, no. 6, pp. 357–379, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Cuatrecasas, C. Alegre, and F. F. Casanueva, “GH/IGF1 axis disturbances in the fibromyalgia syndrome: is there a rationale for GH treatment?” Pituitary, vol. 17, no. 3, pp. 277–283, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Savastano, C. Di Somma, L. Barrea, and A. Colao, “The complex relationship between obesity and the somatropic axis: the long and winding road,” Growth Hormone & IGF Research, vol. 24, no. 6, pp. 221–226, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Okifuji and B. D. Hare, “The association between chronic pain and obesity,” Journal of Pain Research, vol. 8, pp. 399–408, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Ursini, S. Naty, and R. D. Grembiale, “Fibromyalgia and obesity: the hidden link,” Rheumatology International, vol. 31, no. 11, pp. 1403–1408, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Arreghini, G. M. Manzoni, G. Castelnuovo, C. Santovito, and P. Capodaglio, “Impact of fibromyalgia on functioning in obese patients undergoing comprehensive rehabilitation,” PLoS, One, vol. 9, no. 3, article e91392, 2014. View at Google Scholar
  10. A. A. Saber, M. J. Boros, T. Mancl, M. H. Elgamal, S. Song, and T. Wisadrattanapong, “The effect of laparoscopic roux-en-Y gastric bypass on fibromyalgia,” Obesity Surgery, vol. 18, no. 6, pp. 652–655, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. D. E. Berryman, C. A. Glad, E. O. List, and G. Johannsson, “The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations,” Nature Reviews Endocrinology, vol. 9, no. 6, pp. 346–356, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Wolfe, D. J. Clauw, M. A. Fitzcharles et al., “The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity,” Arthritis Care & Research (Hoboken), vol. 62, no. 5, pp. 600–610, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Corneli, C. Di Somma, R. Baldelli et al., “The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index,” European Journal of Endocrinology, vol. 153, no. 2, pp. 257–264, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. K. C. Yuen, R. M. Bennett, C. A. Hryciw, M. B. Cook, S. A. Rhoads, and D. M. Cook, “Is further evaluation for growth hormone (GH) deficiency necessary in fibromyalgia patients with low serum insulin-like growth factor (IGF)-I levels?” Growth Hormone & IGF Research, vol. 17, no. 1, pp. 82–88, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. E. E. Müller, V. Locatelli, and D. Cocchi, “Physiol neuroendocrine control of growth hormone secretion,” Physiology Reviews, vol. 79, no. 2, pp. 511–607, 1999. View at Google Scholar
  16. M. Maccario, C. Gauna, M. Procopio et al., “Assessment of GH/IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH+arginine test,” Journal of Endocrinological Investigation, vol. 22, no. 6, pp. 424–429, 1999. View at Publisher · View at Google Scholar
  17. S. G. Rao, J. F. Gendreau, and J. D. Kranzler, “Understanding the fibromyalgia syndrome,” Psychopharmacology Bulletin, vol. 40, no. 4, pp. 24–67, 2007. View at Google Scholar
  18. E. S. Paiva, A. Deodhar, K. D. Jones, and R. Bennett, “Impaired growth hormone secretion in fibromyalgia patients: evidence for augmented hypothalamic somatostatin tone,” Arthritis & Rheumatology, vol. 46, no. 5, pp. 1344–1350, 2002. View at Google Scholar
  19. G. Bedogni, F. Agosti, A. De Col, N. Marazzi, A. Tagliaferri, and A. Sartorio, “Comparison of dual-energy X-ray absorptiometry, air displacement plethysmography and bioelectrical impedance analysis for the assessment of body composition in morbidly obese women,” European Journal of Clinical Nutrition, vol. 67, no. 11, pp. 1129–1132, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Cuatrecasas, C. Alegre, J. Fernandez-Solà et al., “Growth hormone treatment for sustained pain reduction and improvement in quality of life in severe fibromyalgia,” Pain, vol. 153, no. 7, pp. 1382–1389, 2012. View at Publisher · View at Google Scholar · View at Scopus